Dr. Hammers on Combination of Vaccines and Immune Checkpoint Inhibitors in RCC | OncLive

Dr. Hammers on Combination of Vaccines and Immune Checkpoint Inhibitors in RCC

May 5, 2017

Hans J. Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the combination of vaccines and immune checkpoint inhibitors in the treatment of patients with renal cell carcinoma.

Hans J. Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the combination of vaccines and immune checkpoint inhibitors in the treatment of patients with renal cell carcinoma (RCC).

It is time to revisit vaccines, Hammers says, particularly in combinations. Approaches to this include allogenic vaccines for easy, over-the-counter use, and tailor-made vaccines to fit the needs of a specific patient.


x